General Genomics

FaithWorks Capital’s investment in General Genomics strengthens our portfolio by integrating cutting-edge genomic technology into our medical businesses. This aligns with our mission to enhance healthcare through innovative technology. The genomics industry is expected to experience exponential growth, with advances in medical technology driving demand for personalized medicine solutions, making this a key strategic investment.